
HBHL Scientific Director Alan Evans receives Order of Canada
Original article by The Neuro.
Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honoursA career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

Nine McGillians appointed to the Order of Canada
Neuroscientist Alan Evans and music performance scholar Michael McMahon among McGill community members recognized for exceptional accomplishments and service
Nine members of the McGill University community have been appointed to the Order of Canada, one of the country’s highest civilian honours.
Among the honorees are two McGill faculty members, Professors Alan Evans (Faculty of Medicine and Health Sciences) and Michael McMahon (Schulich School of Music).

Alan Evans receives Order of Canada
Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honoursA career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

Dietetics students help MUHC mark National Indigenous Peoples Day with a special meal
Earlier this month, the McGill University Health Centre (MUHC) marked National Indigenous Peoples Day (June 21) with a special Indigenous-inspired cafeteria meal, featuring baked salmon, wild rice salad, and blueberry bannock.

Human genetics professor receives Banting Discovery Award
Sirui Zhou, Assistant Professor in the Department of Human Genetics, has been awarded a prestigious 2025 Banting Discovery Foundation’s Discovery Award. The award program recognizes innovative biomedical health research projects led by outstanding new investigators at universities and research institu

McGill’s President honours outstanding early-career researchers
Professors Guojun Chen, Mahsa Dadar and Phoebe Friesen – all members of the Faculty of Medicine and Health Sciences – win President’s Prize for Outstanding Emerging ResearchersThree McGill scholars were recognized with the 2025 President’s Prize for Outstanding Emerging Researchers at the Health Sciences Convocation Ceremony on May 27.

The Child Phonology Lab at SCSD is looking for parent participants

Provost honours 31 McGill professors for exceptional research achievements
McGill announces 2025 cohort of Distinguished James McGill Professors, James McGill Professors and William Dawson Scholars
McGill Cares: Building your team for unplanned life transitions
Join us on May 7th at noon for the next McGill Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a loved one with dementia.
Cross-pollinating ideas at the SCSD Research Day
Student presenters at the SCSD Research Day, which took place on February 21, 2025.

AI analysis of healthcare records reveals key factors in autism diagnosis
Scientists argue the criteria we use for diagnosing autism may need revisionWithout clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer
Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro
Free, online training program strengthens training and brings specialized care to communities across QuebecA healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub.

Latest Alzheimer’s drug shown less effective in females than males
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

Genetic sequencing project receives more than $8 million in funding
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians
A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.